Advance Agrolife IPO Date, Review, Price and Key Information

Advance Agrolife Limited IPO is fully book build issue and total IPO size is ₹[] crores. The total offering consists of 19285720 shares.

The dates for the Advance Agrolife Limited IPO have not been announced yet. The allotment process is expected to be finalized by [.].

The Advance Agrolife Limited IPO is scheduled to list on BSE, NSE, with a listing date of [.]. The price band for the Advance Agrolife Limited IPO has not been announced yet.

Registrar for this IPO is Kfin Technologies Limited and lead managers for Advance Agrolife Limited IPO are Choice Capital Advisors Private Limited.

IPO Schedule

IPO Open Date	-
IPO Close Date	-
IPO Allotment Date	-
Refund Initiation	-
Share credit in Demat	-
Listing Date	-

Key Details

Price Band	TBA
Lot Size	TBA
Face Value	₹10 Per Equity Share
Total Issue Size	19,285,720 Shares
Fresh Issue	19,285,720 Shares
Issue Type	Fresh Issue
Listing At	BSE, NSE

Share Reservation

Investor Category	Shares Offered
QIB	50%
Retail	35%
NII/HNI	15%

About Advance Agrolife Limited Company

PI Industries focuses on manufacturing and distributing agrochemicals, specialty fertilizers, and seeds. Their portfolio includes insecticides, herbicides, fungicides, and plant health products, serving both domestic and international markets. In FY24, PI Industries reported Net Sales of ₹7,665.80 Crore and an Operating Profit (EBITDA) of ₹2,025.20 Crore, with an impressive Operating Margin of 26.42%. Net Profit stood at ₹1,681.50 Crore, resulting in a Net Profit Margin of 21.94%.

Sharda Cropchem, founded in 1987, specializes in crop protection chemicals, dyes, and general chemicals, operating globally. Sharda Cropchem's Net Sales for FY24 were ₹3,163.03 Crore, with an Operating Profit (EBITDA) of ₹282.86 Crore and an Operating Margin of 8.94%. Net Profit for the year was ₹31.91 Crore, yielding a Net Profit Margin of 1.01%.

GSP Crop Science, established in 1985, manufactures and markets crop protection solutions. The company operates multiple manufacturing facilities in Gujarat. GSP Crop Science reported Net Sales of ₹1,152.16 Crore in FY24, with an Operating Profit (EBITDA) of ₹124.34 Crore and an Operating Margin of 10.79%. Net Profit was ₹55.54 Crore, resulting in a Net Profit Margin of 4.82%.

Advance Agrolife Limited (AAL) is engaged in manufacturing agrochemical products that support the entire lifecycle of crops. It has reported consistent growth in margins reflecting resilience against headwinds by mitigating costs and increased efficiency. Advance Agrolife has also delivered the highest Return on Equity (ROE), consistently maintained above 25%, and rose to approximately 33% in FY24.

Advance Agrolife Limited Financial Details

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	349.50	259.56	179.47	118.89
Revenue	299.26	455.90	397.81	250.75
Profit After Tax	21.44	24.73	14.87	8.99
Net Worth	96.67	75.26	50.60	35.70
Reserves and Surplus	92.17	70.76	46.10	31.20
Total Borrowing	45.55	45.39	25.18	21.06

₹ In Crore

Key Performance Indicator

Basic EPS (in ₹)	Return on Net Worth (RoNW)	Net Asset Value (NAV)	Debt-Equity Ratio	Return on Equity (ROE)	Return on Capital Employed (ROCE)
5.50	39.30	16.73	0.60		37.62

Offer Objectives

Analysis of the Offer Objects reveals key details regarding share transfers, shareholder structure, lock-in periods, and the intended use of issue proceeds. Several equity share transfers occurred, with a notable gift of 220,000 shares by Sita Kumari Choudhary to Kedar Choudhary on January 4, 2022. A series of cash-based transfers also took place on October 18, 2023, involving various individuals.

The shareholding pattern indicates that Om Prakash Choudhary and Kedar Choudhary hold significant portions of the equity share capital, with 54.17% and 36.05% respectively. Other major shareholders include Geeta Choudhary, Manisha Choudhary, and Kamla Devi.

Promoters, including Om Prakash Choudhary, Kedar Choudhary, Geeta Choudhary, and Manisha Choudhary, have a specified number of equity shares locked-in for a defined period. The funds raised from the issue are primarily intended for funding working capital requirements, with ₹135 crore allocated for this purpose and deployed over Fiscal Years 2026 and 2027. A portion is also earmarked for general corporate purposes, not exceeding 25% of the gross proceeds.

The company's working capital requirements are driven by increased trade receivables and inventory levels. The additional working capital will enable efficient management of the receivables cycle while maintaining operational liquidity and sustaining business growth. Trade receivables will amount to ₹32.53 crore by fiscal year 2027. These capital requirements are supported by the company's growing business and expansion plans.